Sensitivity of different resistant tumour cell lines to the two novel compounds (2Z,4E)-2-methylsulfanyl-5-(1-naphthyl)-4-nitro-2,4-pentadienoate and (1E,3E)-1,4-bis(2-naphthyl)-2,3-dinitro-1,3-butadiene

European Journal of Pharmacology

Volumn 588, Issue 1, 2008, Pages 47-51

  Viale, Maurizio ^a   Petrillo, Giovanni ^b   Maccagno, Massimo ^b   Castagnola, Patrizio ^a   Aiello, Cinzia ^a   Cordazzo, Cinzia ^a   Mariggiò, Maria A ^c   Jadhav, Sushilkumar A ^b   Bianchi, Lara ^b   Leto, Giuseppe ^d   Rizzato, Egon ^d   Poggi, Alessandro ^a   Spinelli, Domenico ^d  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

1 Naph NMCB; 2 Naph DNB; Drug resistance; Mechanism of resistance

Indexed keywords

1,4 BIS(2 NAPHTHYL) 2,3 DINITRO 1,3 BUTADIENE; 2 METHYLSULFANYL 5 (1 NAPHTHYL) 4 NITRO 2,4 PENTADIENOATE; ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; FLUOROURACIL; PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN A549-T12; CONTROLLED STUDY; CROSS RESISTANCE; CYTOTOXICITY; DRUG INHIBITION; DRUG MECHANISM; DRUG TARGETING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MICROTUBULE; MUTATION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BUTADIENES; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FATTY ACIDS, UNSATURATED; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MICROTUBULES; NAPHTHALENES; TETRAZOLIUM SALTS; THIAZOLES;

EID: 44449169296     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.04.020     Document Type: Article

References (17)

1. Alaoui Jamali M.A., Yin M.B., Mazzoni A., Bankusli I., and Rustum Y.M. Relationship between cytotoxicity, drug accumulation, DNA damage and repair of human ovarian cancer cells treated with doxorubicin: modulation by the tiapamil analog RO11-2933. Cancer Chemother. Pharmacol. 25 (1989) 77-83
2. Aschele C., Sobrero A., Faderan M.A., and Bertino J.R. Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules. Cancer Res. 52 (1992) 1855-1864
3. Crisòstomo F.R.P., Carrillo R., Leòn L.G., Martìn T., Padròn J.M., and Martin V.S. Molecular simplification in bioactive molecules: formal synthesis of (+)-muconin. J. Org. Chem. 71 (2006) 2339-2345
4. Dell'Erba C., Chiavarina B., Fenoglio C., Petrillo G., Codazzo C., Boncompagni E., Spinelli D., Ognio E., Aiello C., Mariggiò M.A., and Viale M. Inhibition of cell proliferation, cytotoxicity and induction of apoptosis of 1,4-bis(1-naphthyl)-2,3-dinitro-1,3-butadiene in gastrointestinal tumor cell lines and preliminary evaluation of its toxicity in vivo. Pharmacol. Res. 52 (2005) 271-282
5. Gonçalves A., Braguer D., Kamath K., Martello L., Briand C., Horwitz S., Wilson L., and Jordan M.A. Resistance to taxol in lung cancer cells associated with increased microtubule dynamics. Proc. Natl. Acad. Sci. 98 (2001) 11737-11741
6. Hussain R.F., Nouri A.M.E., and Oliver R.T.D. A new approach for measurement of cytotoxicity using colorimetric assay. J. Immunol. Methods 160 (1993) 89-96
7. Kavallaris M., Kuo D.Y.S., Burkhart C.A., Regi D.L., Norris M.D., Haber M., and Horwitz S.B. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific β-tubulin isotypes. J. Clin. Invest. 100 (1997) 1282-1293
8. Kowalski R.J., Giannakakou P., and Hamel E. Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol(R)). J. Biol. Chem. 272 (1997) 2534-2541
9. Liebmann J.E., Hahn S.M., Cook J.A., Lipschultz C., Mitchell J.B., and Kaufman D.C. Glutathione depletion by l-buthionine sulfoximine antagonizes taxol cytotoxicity. Cancer Res. 53 (1993) 2066-2070
10. Manetti D., Ghelardini C., Bartolini A., Dei S., Galeotti N., Gualtieri F., Romanelli M.N., and Teodori E. Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity. J. Med. Chem. 43 (2000) 4499-4507
11. Novi M., Ottone M., Dell'Erba C., Barbieri F., Chiavarina B., Maccagno M., and Viale M. 1,4-bis(1-naphthyl)-2,3-dinitro-1,3-butadiene: a novel anticancer compound effective against tumor cell lines characterized by different mechanisms of resistance. Oncol. Rep. 12 (2004) 91-96
12. Petrillo G., Fenoglio C., Ognio E., Aiello C., Spinelli D., Mariggiò M.A., Maccagno M., Morganti S., Cordazzo C., and Viale M. Naphthylnitrobutadienes as pharmacologically active molecules: evaluation of the in vivo antitumour activity. Invest. New Drug. 25 (2007) 535-544
13. Petrillo G., Mariggiò M.A., Aiello C., Cordazzo C., Fenoglio C., Morganti S., Croce M., Rizzato E., Spinelli D., Maccagno M., Bianchi L., Prevosto C., Tavani C., and Viale M. Design, synthesis and in vitro evaluation of new naphthylnitrobutadienes with potential antiproliferative activity: towards a structure/activity correlation. Biorg. Med. Chem. 16 (2008) 240-247
14. Richon V.M., Schulte N., and Eastman A. Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II) in murine leukemia L1210 cells. Cancer Res. 47 (1987) 2056-2061
15. Viale M., Ottone M., Chiavarina B., Mariggiò M.A., Prevosto C., Dell'Erba C., Petrillo G., and Novi M. Preliminary evaluation in vitro of the inhibition of cell proliferation, cytotoxicity and induction of apoptosis by 1,4-bis(1-naphthyl)-2,3-dinitro-1,3-butadiene. Invest. New. Drug. 22 (2004) 359-367
16. Viale M., Petrillo G., Aiello C., Fenoglio C., Cordazzo C., Mariggiò M.A., Cassano A., Prevosto C., Ognio E., Maccagno M., Bianchi L., Vaccarone R., Rizzato E., and Spinelli D. Synthesis, in vitro activity and in vivo toxicity of the new 2,3-dinitrobutadiene derivative (1E,3E)-1,4-bis(2-naphthyl)-2,3-dinitro-1,3-butadiene. J. Pharmacol. Res. 56 (2007) 318-328
17. Wehland J., Henkart M., Klausner R., and Sandoval I.V. Role of microtubules in the distribution of the Golgi apparatus: effect of taxol and microinjected anti-alpha-tubulin antibodies. Proc. Natl. Acad. Sci. 80 (1983) 4286-4290